Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1782) 1782
science & technology (1614) 1614
life sciences & biomedicine (1572) 1572
male (1163) 1163
female (1156) 1156
hematology (1022) 1022
child (938) 938
oncology (909) 909
adolescent (902) 902
child, preschool (736) 736
precursor cell lymphoblastic leukemia-lymphoma - mortality (670) 670
adult (598) 598
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (592) 592
prognosis (582) 582
infant (554) 554
leukemia (520) 520
treatment outcome (479) 479
precursor cell lymphoblastic leukemia-lymphoma - therapy (469) 469
acute lymphocytic leukemia (463) 463
middle aged (449) 449
biological and medical sciences (445) 445
medical sciences (444) 444
precursor cell lymphoblastic leukemia-lymphoma - genetics (432) 432
acute lymphoblastic leukemia (419) 419
cancer (411) 411
pediatrics (386) 386
antineoplastic combined chemotherapy protocols - therapeutic use (365) 365
precursor cell lymphoblastic leukemia-lymphoma - pathology (362) 362
chemotherapy (349) 349
disease-free survival (347) 347
hematologic and hematopoietic diseases (344) 344
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (335) 335
young adult (317) 317
survival rate (315) 315
risk factors (296) 296
recurrence (294) 294
acute lymphatic leukemia (279) 279
aged (278) 278
children (268) 268
care and treatment (263) 263
retrospective studies (260) 260
transplantation (253) 253
remission induction (244) 244
research (244) 244
survival analysis (244) 244
precursor cell lymphoblastic leukemia-lymphoma - diagnosis (228) 228
health aspects (214) 214
precursor b-cell lymphoblastic leukemia-lymphoma - mortality (198) 198
lymphatic leukemia (192) 192
analysis (190) 190
follow-up studies (187) 187
stem cells (181) 181
hematopoietic stem cell transplantation (177) 177
abridged index medicus (174) 174
animals (165) 165
genetic aspects (160) 160
transplantation, homologous (156) 156
bone marrow (153) 153
antineoplastic agents - therapeutic use (147) 147
hematology, oncology and palliative medicine (146) 146
precursor b-cell lymphoblastic leukemia-lymphoma - genetics (144) 144
hematopoietic stem cells (142) 142
patients (142) 142
philadelphia chromosome (138) 138
immunology (133) 133
medicine & public health (132) 132
t cells (132) 132
precursor cell lymphoblastic leukemia-lymphoma - complications (127) 127
immunophenotyping (124) 124
survival (124) 124
minimal residual disease (122) 122
precursor cell lymphoblastic leukemia-lymphoma - epidemiology (114) 114
antineoplastic combined chemotherapy protocols - adverse effects (112) 112
combined modality therapy (112) 112
hemic and lymphatic diseases (112) 112
precursor cell lymphoblastic leukemia-lymphoma - immunology (112) 112
age factors (111) 111
gene expression (111) 111
tumors (111) 111
all (110) 110
precursor b-cell lymphoblastic leukemia-lymphoma - drug therapy (110) 110
stem cell transplantation (110) 110
patient outcomes (108) 108
kaplan-meier estimate (107) 107
infant, newborn (106) 106
mice (106) 106
diagnosis (105) 105
precursor cell lymphoblastic leukemia-lymphoma - metabolism (105) 105
neoplasm, residual (103) 103
relapse (101) 101
acute lymphoblastic leukaemia (99) 99
mutation (98) 98
mortality (97) 97
remission (96) 96
antineoplastic combined chemotherapy protocols - administration & dosage (95) 95
antineoplastic agents (94) 94
precursor b-cell lymphoblastic leukemia-lymphoma - pathology (93) 93
vincristine - administration & dosage (93) 93
aged, 80 and over (90) 90
medical prognosis (90) 90
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1791) 1791
Chinese (12) 12
Japanese (8) 8
German (7) 7
French (3) 3
Portuguese (3) 3
Norwegian (2) 2
Russian (2) 2
Spanish (2) 2
Danish (1) 1
Italian (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia
by Spinelli, Orietta and Peruta, Barbara and Tosi, Manuela and Guerini, Vittoria and Salvi, Anna and Zanotti, Maria Cristina and Oldani, Elena and Grassi, Anna and Intermesoli, Tamara and Mico, Caterina and Rossi, Giuseppe and Fabris, Pietro and Lambertenghi-Deliliers, Giorgio and Angelucci, Emanuele and Barbui, Tiziano and Bassan, Renato and Rambaldi, Alessandro
Haematologica (Roma), ISSN 0390-6078, 05/2007, Volume 92, Issue 5, pp. 612 - 618
Ph | ALL | Allogeneic transplantation | MRD | Adult ALL | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Bone marrow, stem cells transplantation. Graft versus host reaction | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Translocation, Genetic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - surgery | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Gene Deletion | Fusion Proteins, bcr-abl - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - blood | Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood | Basic Helix-Loop-Helix Transcription Factors - genetics | Hematopoietic Stem Cell Transplantation | Survival Rate | Combined Modality Therapy | Remission Induction | Adolescent | Survival Analysis | Oncogene Proteins, Fusion - blood | Kinetics | Transplantation Conditioning | Cohort Studies | Piperazines - administration & dosage | Clinical Trials as Topic - statistics & numerical data | Precursor Cell Lymphoblastic Leukemia-Lymphoma - surgery | Risk | Transplantation, Homologous | Neoplasm, Residual | Multicenter Studies as Topic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Polymerase Chain Reaction | Adult | Female | Myeloid-Lymphoid Leukemia Protein - blood | Gene Rearrangement, B-Lymphocyte | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | T-Cell Acute Lymphocytic Leukemia Protein 1 | Leukemia-Lymphoma, Adult T-Cell - genetics | Leukemia-Lymphoma, Adult T-Cell - surgery | Pyrimidines - administration & dosage | Gene Rearrangement, T-Lymphocyte | Leukemia-Lymphoma, Adult T-Cell - mortality | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Imatinib Mesylate | Biomarkers, Tumor - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Leukemia-Lymphoma, Adult T-Cell - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Benzamides | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
by Gökbuget, Nicola and Dombret, Hervé and Bonifacio, Massimiliano and Reichle, Albrecht and Graux, Carlos and Faul, Christoph and Diedrich, Helmut and Topp, Max S and Brüggemann, Monika and Horst, Heinz-August and Havelange, Violaine and Stieglmaier, Julia and Wessels, Hendrik and Haddad, Vincent and Benjamin, Jonathan E and Zugmaier, Gerhard and Nagorsen, Dirk and Bargou, Ralf C
Blood, ISSN 0006-4971, 04/2018, Volume 131, Issue 14, pp. 1522 - 1531
Life Sciences & Biomedicine | Hematology | Science & Technology | Recurrence | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Male | Survival Rate | Neoplasm, Residual | Disease-Free Survival | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antibodies, Bispecific - adverse effects | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Antibodies, Bispecific - administration & dosage | Adolescent | Adult | Female | Aged | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - blood | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: A combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)
by Schultz, Kirk R and Pullen, D. Jeanette and Sather, Harland N and Shuster, Jonathan J and Devidas, Meenakshi and Borowitz, Michael J and Carroll, Andrew J and Heerema, Nyla A and Rubnitz, Jeffrey E and Loh, Mignon L and Raetz, Elizabeth A and Winick, Naomi J and Hunger, Stephen P and Carroll, William L and Gaynon, Paul S and Camitta, Bruce M
Blood, ISSN 0006-4971, 02/2007, Volume 109, Issue 3, pp. 926 - 935
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Prognosis | Humans | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Neoplasm, Residual | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Classification | Adult | Female | Retrospective Studies | Cytogenetic Analysis | Child | Risk Assessment | Treatment Outcome | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Algorithms | Adolescent | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - classification | Biomarkers | Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B‐cell acute lymphoblastic leukemia
by Jabbour, Elias and Short, Nicholas J and Jorgensen, Jeffrey L and Yilmaz, Musa and Ravandi, Farhad and Wang, Sa A and Thomas, Deborah A and Khoury, Joseph and Champlin, Richard E and Khouri, Issa and Kebriaei, Partow and O'Brien, Susan M and Garcia‐Manero, Guillermo and Cortes, Jorge E and Sasaki, Koji and Dinardo, Courtney D and Kadia, Tapan M and Jain, Nitin and Konopleva, Marina and Garris, Rebecca and Kantarjian, Hagop M
Cancer, ISSN 0008-543X, 01/2017, Volume 123, Issue 2, pp. 294 - 302
relapsed | refractory | inotuzumab | blinatumomab | minimal residual disease | acute lymphoblastic leukemia | Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasm, Residual - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Antineoplastic Agents - therapeutic use | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Young Adult | Disease-Free Survival | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Stem Cell Transplantation - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adolescent | Aged, 80 and over | Adult | Aged | B-Lymphocytes - pathology | Hematopoietic Stem Cell Transplantation - methods | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Salvage Therapy - methods | Flow cytometry | Cell survival | Acute lymphatic leukemia | Leukemia | Minimal residual disease | Stem cell transplantation | Transplantation | Lymphatic leukemia | Patients | Survival | Doxorubicin | Vincristine | Cytometry | Cyclophosphamide | Salvage | Lymphocytes B | Stem cells | Remission | Adults | Cancer | Index Medicus | Abridged Index Medicus | Acute lymphoblastic leukemia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
by Migliorini, Gabriele and Migliorini, Gabriele and Fiege, Bettina and Fiege, Bettina and Hosking, Fay J and Hosking, Fay J and Ma, Yussanne and Ma, Yussanne and Kumar, Rajiv and Kumar, Rajiv and Sherborne, Amy L and Sherborne, Amy L and da Silva Filho, Miguel Inacio and Da Silva Filho, Miguel Inacio and Vijayakrishnan, Jayaram and Vijayakrishnan, Jayaram and Koehler, Rolf and Koehler, Rolf and Thomsen, Hauke and Thomsen, Hauke and Irving, Julie A and Irving, Julie A and Allan, James M and Allan, James M and Lightfoot, Tracy and Lightfoot, Tracy and Roman, Eve and Roman, Eve and Kinsey, Sally E and Kinsey, Sally E and Sheridan, Eamonn and Sheridan, Eamonn and Thompson, Pamela and Thompson, Pamela and Hoffmann, Per and Hoffmann, Per and Nöthen, Markus M and Nöthen, Markus M and Mühleisen, Thomas W and Mühleisen, Thomas W and Eisele, Lewin and Eisele, Lewin and Zimmermann, Martin and Zimmermann, Martin and Bartram, Claus R and Bartram, Claus R and Schrappe, Martin and Schrappe, Martin and Greaves, Mel and Greaves, Mel and Stanulla, Martin and Stanulla, Martin and Hemminki, Kari and Hemminki, Kari and Houlston, Richard S and Houlston, Richard S
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 19, pp. 3298 - 3307
Life Sciences & Biomedicine | Hematology | Science & Technology | GATA3 Transcription Factor - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Age Factors | Exons | Humans | Middle Aged | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Genetic Loci | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Female | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Child | B-Lymphocytes - metabolism | Genetic Predisposition to Disease | Genome-Wide Association Study | Introns | Phosphotransferases (Alcohol Group Acceptor) - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Phenotype | Alleles | Survival Analysis | Polymorphism, Single Nucleotide | Chromosomes, Human, Pair 10 | Index Medicus | Abridged Index Medicus | Clinical Medicine | Hematologi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
by Roberts, Kathryn G and Li, Yongjin and Payne-Turner, Debbie and Harvey, Richard C and Yang, Yung-Li and Pei, Deqing and McCastlain, Kelly and Ding, Li and Lu, Charles and Song, Guangchun and Ma, Jing and Becksfort, Jared and Rusch, Michael and Chen, I-Ming and Chen, Xiang and Chen, Shann-Ching and Easton, John and Cheng, Jinjun and Cheng, Cheng and Boggs, Kristy and Santiago-Morales, Natalia and Iacobucci, Ilaria and Fulton, Robert S and Wen, Ji and Valentine, Marcus and Paugh, Steven W and Devidas, Meenakshi and Reshmi, Shalini and Smith, Malcolm A and Smith, Amy and Hedlund, Erin and Gupta, Pankaj and Nagahawatte, Panduka and Wu, Gang and Yergeau, Donald and Vadodaria, Bhavin and Mulder, Heather and Winick, Naomi J and Larsen, Eric C and Carroll, Andrew J and Carroll, William L and Heerema, Nyla A and Grayson, Guy and Tasian, Sarah K and Moore, Andrew S and Keller, Frank and Frei-Jones, Melissa and Whitlock, James A and Raetz, Elizabeth A and White, Deborah L and Hughes, Timothy P and Guidry Auvil, Jaime M and Marcucci, Guido and Bloomfield, Clara D and Mrózek, Krzysztof and Kohlschmidt, Jessica and Stock, Wendy and Kornblau, Steven M and Konopleva, Marina and Paietta, Elisabeth and Pui, Ching-Hon and Jeha, Sima and Relling, Mary V and Evans, William E and Gerhard, Daniela S and Gastier-Foster, Julie M and Mardis, Elaine and Wilson, Richard K and Loh, Mignon L and Downing, James R and Hunger, Stephen P and Willman, Cheryl L and Zhang, Jinghui and Mullighan, Charles G
The New England journal of medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 1005 - 1015
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Oligonucleotide Array Sequence Analysis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Child, Preschool | Infant | Male | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Heterografts | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | DNA, Neoplasm - analysis | Receptors, Cytokine - metabolism | Child | Philadelphia Chromosome | Receptors, Cytokine - genetics | Signal Transduction - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Adolescent | Survival Analysis | Mice | Polymorphism, Single Nucleotide | Genome, Human | Protein-Tyrosine Kinases - antagonists & inhibitors | Development and progression | Care and treatment | Genetic aspects | Research | Lymphocytic leukemia | Tyrosine metabolism | Cell proliferation | Tyk2 protein | Leukemia | Genes | Clinical trials | Oncology | Genomes | Kinases | Cell activation | Janus kinase 2 | Xenografts | Teenagers | Children | Adolescents | Protein-tyrosine kinase | Age | Tyrosine | Young adults | Genomic analysis | Acute lymphatic leukemia | Stat5 protein | Lymphatic leukemia | Gene expression | Philadelphia chromosome | Interleukin 7 receptors | Thymic stromal lymphopoietin | Lymphocytes B | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia
by Mueller, Karen Thudium and Waldron, Edward and Grupp, Stephan A and Levine, John E and Laetsch, Theodore W and Pulsipher, Michael A and Boyer, Michael W and August, Keith J and Hamilton, Jason and Awasthi, Rakesh and Stein, Andrew M and Sickert, Denise and Chakraborty, Abhijit and Levine, Bruce L and June, Carl H and Tomassian, Lori and Shah, Sweta S and Leung, Mimi and Taran, Tetiana and Wood, Patricia A and Maude, Shannon L
Clinical cancer research, ISSN 1078-0432, 12/2018, Volume 24, Issue 24, pp. 6175 - 6184
Life Sciences & Biomedicine | Oncology | Science & Technology | Cell- and Tissue-Based Therapy - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Prognosis | Humans | Child, Preschool | Male | Receptors, Antigen, T-Cell | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - immunology | Young Adult | Immunity, Humoral | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | Child | Antigens, CD19 - immunology | Immunotherapy, Adoptive - adverse effects | Immunotherapy, Adoptive - methods | Transgenes - genetics | Treatment Outcome | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Animals | Adolescent | Lymphocyte Count | Mice | Cell- and Tissue-Based Therapy - adverse effects | Genetic Therapy - adverse effects | Genetic Therapy - methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
by Kantarjian, Hagop and Stein, Anthony and Gökbuget, Nicola and Fielding, Adele K and Schuh, Andre C and Ribera, Josep-Maria and Wei, Andrew and Dombret, Hervé and Foà, Robin and Bassan, Renato and Arslan, Önder and Sanz, Miguel A and Bergeron, Julie and Demirkan, Fatih and Lech-Maranda, Ewa and Rambaldi, Alessandro and Thomas, Xavier and Horst, Heinz-August and Brüggemann, Monika and Klapper, Wolfram and Wood, Brent L and Fleishman, Alex and Nagorsen, Dirk and Holland, Christopher and Zimmerman, Zachary and Topp, Max S
The New England journal of medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 9, pp. 836 - 847
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Transplantation, Homologous | Stem Cell Transplantation | Young Adult | Antibodies, Bispecific - therapeutic use | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antibodies, Bispecific - adverse effects | Sepsis - chemically induced | Antineoplastic Agents - adverse effects | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Chemotherapy | Usage | Care and treatment | Acute lymphocytic leukemia | Diagnosis | Comparative analysis | Patients | Cancer | CD19 antigen | Acute lymphatic leukemia | Cell survival | Writers | Clinical trials | Stem cell transplantation | Lymphocytes T | CD3 antigen | Lymphatic leukemia | Lymphocytes B | Medical prognosis | Monoclonal antibodies | Remission | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
by Maude, Shannon L and Laetsch, Theodore W and Buechner, Jochen and Rives, Susana and Boyer, Michael and Bittencourt, Henrique and Bader, Peter and Verneris, Michael R and Stefanski, Heather E and Myers, Gary D and Qayed, Muna and De Moerloose, Barbara and Hiramatsu, Hidefumi and Schlis, Krysta and Davis, Kara L and Martin, Paul L and Nemecek, Eneida R and Yanik, Gregory A and Peters, Christina and Baruchel, Andre and Boissel, Nicolas and Mechinaud, Francoise and Balduzzi, Adriana and Krueger, Joerg and June, Carl H and Levine, Bruce L and Wood, Patricia and Taran, Tetiana and Leung, Mimi and Mueller, Karen T and Zhang, Yiyun and Sen, Kapildeb and Lebwohl, David and Pulsipher, Michael A and Grupp, Stephan A
The New England journal of medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 5, pp. 439 - 448
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Receptors, Antigen, T-Cell - therapeutic use | Child, Preschool | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Receptors, Antigen, T-Cell - antagonists & inhibitors | Remission Induction | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Antigens, CD19 | Female | Infusions, Intravenous | Child | Treatment outcome | Care and treatment | Young adults | Lymphocytic leukemia | Research | Children | Comparative analysis | Health aspects | Flow cytometry | Pediatrics | Edema | Medical research | CD19 antigen | Acute lymphatic leukemia | Transplants & implants | Hematology | Leukemia | Minimal residual disease | Oncology | Lymphocytes T | Lymphatic leukemia | Children & youth | Studies | Chimeric antigen receptors | Lymphocytes B | Stem cells | Bone marrow | Remission | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights